He Y, Coutlée F, Saint-Antoine P, Olivier C, Voyer H, Kessous-Elbaz A
Department of Microbiology and Infectious Diseases, Hôpital Notre-Dame, Montréal, Quebec, Canada.
J Clin Microbiol. 1993 May;31(5):1040-7. doi: 10.1128/jcm.31.5.1040-1047.1993.
An enzyme-linked immunoassay (EIA) combined with a solution hybridization (SH) reaction was devised to detect human immunodeficiency virus type 1 (HIV-1) provirus amplified by the polymerase chain reaction (PCR). In this nonisotopic PCR assay, designated PCR-EIASH, a fragment of the HIV-1 gag gene from peripheral blood mononuclear cells (PBMCs) was first amplified with biotinylated primers. The biotinylated amplified DNA segment was reacted in solution with an internal RNA probe labeled with digoxigenin-11-UTP. Hybrids were captured in a microtiter plate coated with streptavidin. Specific bound hybrids were quantitated by the addition of an enzyme-labeled antibody against digoxigenin and a fluorogenic substrate. The hybridization, immunological, and amplification parameters of PCR-EIASH were optimized as follows: 12.5 pmol of each primer was used in the PCR; the reannealing reaction of amplified products with the RNA probe, which was used at 0.30 microgram/ml, was completed in 30 min at 70 degrees C in 2x SSC (1x SSC is 0.15 M NaCl plus 0.015 M sodium citrate). Five copies of HIV-1 DNA diluted in a lysate of 100,000 PBMCs from a seronegative control could be detected by PCR-EIASH with a signal of 41 +/- 3 fluorescent units above a background noise of 13 +/- 2 fluorescent units. A total of 91 PBMC lysates from 91 seropositive patients sampled once and 20 PBMC lysates from 10 seropositive patients sampled twice were tested in duplicate in the PCR-EIASH; 107 samples were positive in duplicate tests, 1 sample was indeterminate, and 3 samples were negative. Of the latter three samples, one became positive by diluting the cell lysate, suggesting the presence of an inhibitor of Taq polymerase. The three samples negative for HIV-1 by PCR-EIASH were also negative when amplified with SK145-SK39 and detected with 32P-labeled SK102.
设计了一种将酶联免疫测定(EIA)与溶液杂交(SH)反应相结合的方法,用于检测通过聚合酶链反应(PCR)扩增的1型人类免疫缺陷病毒(HIV-1)前病毒。在这种非同位素PCR检测方法(称为PCR-EIASH)中,首先用生物素化引物从外周血单核细胞(PBMC)中扩增HIV-1 gag基因片段。生物素化的扩增DNA片段与用地高辛配基-11-UTP标记的内部RNA探针在溶液中反应。杂交体捕获在包被有链霉抗生物素蛋白的微量滴定板中。通过加入抗地高辛配基的酶标记抗体和荧光底物对特异性结合的杂交体进行定量。PCR-EIASH的杂交、免疫和扩增参数优化如下:PCR中每种引物使用12.5 pmol;扩增产物与RNA探针(使用浓度为0.30 μg/ml)的复性反应在70℃下于2×SSC(1×SSC为0.15 M NaCl加0.015 M柠檬酸钠)中30分钟内完成。PCR-EIASH能够检测出在来自血清阴性对照的100,000个PBMC裂解物中稀释的5份HIV-1 DNA拷贝,其信号比13±2个荧光单位的背景噪声高41±3个荧光单位。对来自91例血清阳性患者的91份PBMC裂解物(均为单次采样)和来自10例血清阳性患者的20份PBMC裂解物(均为两次采样)进行了PCR-EIASH重复检测;107份样本重复检测呈阳性,1份样本结果不确定,3份样本呈阴性。在这三份阴性样本中,有一份通过稀释细胞裂解物后变为阳性,提示存在Taq聚合酶抑制剂。通过PCR-EIASH检测为HIV-1阴性的这三份样本,在用SK145-SK39扩增并用32P标记的SK102检测时也为阴性。